Australia is waiting nervously to find out just what Mr Trump has in store for the nation in his so-called “Liberation Day” ...
EDITORIAL: Donald Trump holds the ambitions of Anthony Albanese and Peter Dutton in his hands — whether or not the US ...
At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting ...
The pharmaceutical industry isn’t happy about President Donald Trump’s trade war and is reportedly lobbying the President to slow down drug ...
Large drugmakers have global manufacturing footprints, mainly in the U.S., Europe and Asia, and moving more production to the ...
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...
At Microsoft, we’ve worked with leading innovators across industries, helping them not just experiment with AI, but deploy it ...
The CBI has ruled out gangrape, shifting focus to a potential larger conspiracy and the destruction of evidence. Questions are mounting over the probe's direction, while the victim's father insists ...
Canadian Prime Minister Mark Carney told President Donald Trump Wednesday that his nation will retaliate against the United States with tariffs of its own if Trump presses forward with his promised ...
FTSE 100 fashion retailer Next posted £1bn annual profit in this morning's results. In light of recent trade tariffs, is it ...
NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results